- Home
- RMTI vs GDTC Comparison
RMTI vs GDTC Comparison
Compare RMTI & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- GDTC
- Stock Information
- Founded
- RMTI 1994
- GDTC 2018
- Country
- RMTI United States
- GDTC Singapore
- Employees
- RMTI N/A
- GDTC N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- RMTI Health Care
- GDTC Health Care
- Exchange
- RMTI Nasdaq
- GDTC Nasdaq
- Market Cap
- RMTI 32.5M
- GDTC 28.0M
- IPO Year
- RMTI 1998
- GDTC 2023
- Fundamental
- Price
- RMTI $1.19
- GDTC $2.14
- Analyst Decision
- RMTI Strong Buy
- GDTC Buy
- Analyst Count
- RMTI 2
- GDTC 1
- Target Price
- RMTI $4.00
- GDTC $5.00
- AVG Volume (30 Days)
- RMTI 305.0K
- GDTC 5.9K
- Earning Date
- RMTI 08-07-2025
- GDTC 01-01-0001
- Dividend Yield
- RMTI N/A
- GDTC N/A
- EPS Growth
- RMTI N/A
- GDTC N/A
- EPS
- RMTI N/A
- GDTC N/A
- Revenue
- RMTI $97,727,000.00
- GDTC $368,838.00
- Revenue This Year
- RMTI N/A
- GDTC $5.37
- Revenue Next Year
- RMTI $11.16
- GDTC N/A
- P/E Ratio
- RMTI N/A
- GDTC N/A
- Revenue Growth
- RMTI 12.82
- GDTC N/A
- 52 Week Low
- RMTI $0.78
- GDTC $1.20
- 52 Week High
- RMTI $5.15
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- RMTI 56.72
- GDTC 44.67
- Support Level
- RMTI $0.80
- GDTC $2.08
- Resistance Level
- RMTI $0.87
- GDTC $2.31
- Average True Range (ATR)
- RMTI 0.06
- GDTC 0.11
- MACD
- RMTI 0.01
- GDTC -0.00
- Stochastic Oscillator
- RMTI 94.81
- GDTC 12.18
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.